| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970576 | The Journal of Heart and Lung Transplantation | 2013 | 8 Pages |
Abstract
In this open-label trial, continuous IV treprostinil for 1 year appears to be safe and effective in de novo PAH patients and those transitioned from IV epoprostenol.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Raymond L. MD, Victor F. MD, Mardi MD, MSc, Abigail RRT, Robyn J. MD, Vallerie V. MD,